Report Detail

Other Global Natamycin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2930070
  • |
  • 12 February, 2019
  • |
  • Global
  • |
  • 124 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Scope of the Report:
Raw Materials are important component, occupying for the most proportion of cost. It’s important and necessary to attach importance to raw materials sourcing.
In general, the raw materials need to outsourcing, and the price, on-time rate and quality are very key indicators, to keep competitive market position, to maximize the profit.

Actually, the price, on-time rate or quality, is just one of key factors to influence on the supply capacity and competitiveness. The lowest total production cost is the total index to maximize the profit.

To a producer, can control the total production cost through worldwide procurement, localization procurement and concentrative purchase, more purchasing focuses on fewer suppliers to large-scale purchase, to large-scale and high efficiency. Now the logistics and information is well-developed, beneficial to worldwide procurement, localization procurement and concentrative purchase. In future, more manufacturers will attach importance to the raw materials purchasing,
Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service. The world changes quickly, especially in mobile internet and consumer electronics, and now the mobile internet and consumer electronics are changing the traditional sectors, to more efficient, more cheaper and powerful.
The worldwide market for Natamycin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Natamycin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Natamycin 50%
Natamycin 95%

Market Segment by Applications, can be divided into
Food industry
Medical
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Natamycin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Natamycin, with price, sales, revenue and global market share of Natamycin in 2017 and 2018.
Chapter 3, the Natamycin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Natamycin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Natamycin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Natamycin sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Natamycin Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Natamycin 50%
      • 1.2.2 Natamycin 95%
    • 1.3 Market Analysis by Applications
      • 1.3.1 Food industry
      • 1.3.2 Medical
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Danisco
      • 2.1.1 Business Overview
      • 2.1.2 Natamycin Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Danisco Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 DSM
      • 2.2.1 Business Overview
      • 2.2.2 Natamycin Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 DSM Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 VGP
      • 2.3.1 Business Overview
      • 2.3.2 Natamycin Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 VGP Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Handary
      • 2.4.1 Business Overview
      • 2.4.2 Natamycin Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Handary Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 AMTECH BIOTECH
      • 2.5.1 Business Overview
      • 2.5.2 Natamycin Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 AMTECH BIOTECH Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Silver-Elephant
      • 2.6.1 Business Overview
      • 2.6.2 Natamycin Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Silver-Elephant Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Lanzhou Weiri
      • 2.7.1 Business Overview
      • 2.7.2 Natamycin Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Lanzhou Weiri Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Langfang Meihua
      • 2.8.1 Business Overview
      • 2.8.2 Natamycin Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Langfang Meihua Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Zhengzhou New Frey
      • 2.9.1 Business Overview
      • 2.9.2 Natamycin Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Zhengzhou New Frey Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Chihon
      • 2.10.1 Business Overview
      • 2.10.2 Natamycin Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Chihon Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Jiaozuo Joincare
      • 2.11.1 Business Overview
      • 2.11.2 Natamycin Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Jiaozuo Joincare Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Beijing Oriental Rada
      • 2.12.1 Business Overview
      • 2.12.2 Natamycin Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Beijing Oriental Rada Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Pucheng Lifecome
      • 2.13.1 Business Overview
      • 2.13.2 Natamycin Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Pucheng Lifecome Natamycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Natamycin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Natamycin Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Natamycin Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Natamycin Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Natamycin Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Natamycin Market Analysis by Regions

    • 4.1 Global Natamycin Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Natamycin Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Natamycin Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Natamycin Sales and Growth Rate (2014-2019)
    • 4.3 Europe Natamycin Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Natamycin Sales and Growth Rate (2014-2019)
    • 4.5 South America Natamycin Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Natamycin Sales and Growth Rate (2014-2019)

    5 North America Natamycin by Country

    • 5.1 North America Natamycin Sales, Revenue and Market Share by Country
      • 5.1.1 North America Natamycin Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Natamycin Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Natamycin Sales and Growth Rate (2014-2019)
    • 5.3 Canada Natamycin Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Natamycin Sales and Growth Rate (2014-2019)

    6 Europe Natamycin by Country

    • 6.1 Europe Natamycin Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Natamycin Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Natamycin Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Natamycin Sales and Growth Rate (2014-2019)
    • 6.3 UK Natamycin Sales and Growth Rate (2014-2019)
    • 6.4 France Natamycin Sales and Growth Rate (2014-2019)
    • 6.5 Russia Natamycin Sales and Growth Rate (2014-2019)
    • 6.6 Italy Natamycin Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Natamycin by Country

    • 7.1 Asia-Pacific Natamycin Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Natamycin Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Natamycin Revenue and Market Share by Country (2014-2019)
    • 7.2 China Natamycin Sales and Growth Rate (2014-2019)
    • 7.3 Japan Natamycin Sales and Growth Rate (2014-2019)
    • 7.4 Korea Natamycin Sales and Growth Rate (2014-2019)
    • 7.5 India Natamycin Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Natamycin Sales and Growth Rate (2014-2019)

    8 South America Natamycin by Country

    • 8.1 South America Natamycin Sales, Revenue and Market Share by Country
      • 8.1.1 South America Natamycin Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Natamycin Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Natamycin Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Natamycin Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Natamycin Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Natamycin by Countries

    • 9.1 Middle East and Africa Natamycin Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Natamycin Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Natamycin Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Natamycin Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Natamycin Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Natamycin Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Natamycin Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Natamycin Sales and Growth Rate (2014-2019)

    10 Global Natamycin Market Segment by Type

    • 10.1 Global Natamycin Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Natamycin Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Natamycin Revenue and Market Share by Type (2014-2019)
    • 10.2 Natamycin 50% Sales Growth and Price
      • 10.2.1 Global Natamycin 50% Sales Growth (2014-2019)
      • 10.2.2 Global Natamycin 50% Price (2014-2019)
    • 10.3 Natamycin 95% Sales Growth and Price
      • 10.3.1 Global Natamycin 95% Sales Growth (2014-2019)
      • 10.3.2 Global Natamycin 95% Price (2014-2019)

    11 Global Natamycin Market Segment by Application

    • 11.1 Global Natamycin Sales Market Share by Application (2014-2019)
    • 11.2 Food industry Sales Growth (2014-2019)
    • 11.3 Medical Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Natamycin Market Forecast (2019-2024)

    • 12.1 Global Natamycin Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Natamycin Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Natamycin Market Forecast (2019-2024)
      • 12.2.2 Europe Natamycin Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Natamycin Market Forecast (2019-2024)
      • 12.2.4 South America Natamycin Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Natamycin Market Forecast (2019-2024)
    • 12.3 Natamycin Market Forecast by Type (2019-2024)
      • 12.3.1 Global Natamycin Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Natamycin Market Share Forecast by Type (2019-2024)
    • 12.4 Natamycin Market Forecast by Application (2019-2024)
      • 12.4.1 Global Natamycin Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Natamycin Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Natamycin . Industry analysis & Market Report on Natamycin is a syndicated market report, published as Global Natamycin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Natamycin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,690.04
      4,035.06
      5,380.08
      3,239.88
      4,859.82
      6,479.76
      531,361.20
      797,041.80
      1,062,722.40
      293,712.00
      440,568.00
      587,424.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report